Opportunities and Challenges: Stem Cell‐Based Therapy for the Treatment of Ischemic Stroke

  • Yao‐Hui Tang
    Neuroscience and Neuroengineering Center Med‐X Research Institute and School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China
  • Yuan‐Yuan Ma
    Department of Neurology Ruijin Hospital School of Medicine Shanghai Jiao Tong University Shanghai China
  • Zhi‐Jun Zhang
    Neuroscience and Neuroengineering Center Med‐X Research Institute and School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China
  • Yong‐Ting Wang
    Neuroscience and Neuroengineering Center Med‐X Research Institute and School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China
  • Guo‐Yuan Yang
    Neuroscience and Neuroengineering Center Med‐X Research Institute and School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China

書誌事項

公開日
2015-02-10
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1111/cns.12386
公開者
Wiley

この論文をさがす

説明

<jats:title>Summary</jats:title><jats:p>Stem cell‐based therapy for ischemic stroke has been widely explored in animal models and provides strong evidence of benefits. In this review, we summarize the types of stem cells, various delivery routes, and tracking tools for stem cell therapy of ischemic stroke. MSCs, EPCs, and NSCs are the most explored cell types for ischemic stroke treatment. Although the mechanisms of stem cell‐based therapies are not fully understood, the most possible functions of the transplanted cells are releasing growth factors and regulating microenvironment through paracrine mechanism. Clinical application of stem cell‐based therapy is still in its infancy. The next decade of stem cell research in stroke field needs to focus on combining different stem cells and different imaging modalities to fully explore the potential of this therapeutic avenue: from bench to bedside and vice versa.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ